January 24, 2026
AMH Testing: Key to Predicting Female Fertility
AMH testing accurately predicts ovarian reserve, revealing egg supply and fertility potential with a single blood test. Studies show it outperforms FSH in detecting diminished ovarian reserve, even in women on contraceptives.
Key Takeaways
AMH Testing Explained: Understanding Ovarian Reserve
Anti-Müllerian hormone (AMH) levels correlate directly with the number of immature follicles in the ovaries. Higher AMH indicates greater egg reserves, while undetectable levels signal menopause. It provides an early warning for declining fertility.
How AMH Blood Test Predicts Fertility Treatment Response
Physicians use AMH to tailor IVF protocols, as it reliably predicts both under-response and over-response to stimulation medications. Unlike FSH, AMH remains stable throughout the menstrual cycle, allowing for flexible testing timing.
AMH vs. FSH: Why AMH is a Better Ovarian Reserve Indicator
AMH detects diminished ovarian reserve earlier than FSH, which only rises significantly in later stages. This makes AMH the preferred test for identifying fertility challenges before traditional markers show abnormalities.
Impact of Birth Control on AMH Levels and Fertility Assessment
Continuous combined contraceptives lower AMH levels. For accurate results, testing should occur on day 3 of menstruation, avoiding contraceptive-related distortions that could mislead fertility evaluations.
AMH Levels in PCOS: Linking Hormone Levels to Condition Severity
Women with PCOS exhibit elevated AMH due to increased antral follicles. AMH testing helps differentiate PCOS subtypes, with higher levels correlating to insulin-resistant forms of the condition.
Source: Read full article